The role of microbiota in infectious disease

Trends in Microbiology

Volumn 16, Issue 3, 2008, Pages 107-114

  Stecher, Bärbel ^a   Hardt, Wolf Dietrich ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; DISEASE MODEL; ENTERITIS; GROWTH INHIBITION; INFECTION; INTESTINE FLORA; INTESTINE INFECTION; MICROBIOLOGY; MUCOSA INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; GASTROINTESTINAL TRACT; HUMANS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 39849102964     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2007.12.008     Document Type: Article

References (84)

1. Smith K., et al. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol. 19 (2006) 59-69
2. O'Hara A.M., and Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 7 (2006) 688-693
3. Bry L., et al. A model of host-microbial interactions in an open mammalian ecosystem. Science 273 (1996) 1380-1383
4. Klaasen H.L., et al. Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect. Immun. 61 (1993) 303-306
5. Stappenbeck T.S., et al. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15451-15455
6. Lopez-Boado Y.S., et al. Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J. Cell Biol. 148 (2000) 1305-1315
7. Keilbaugh S.A., et al. Activation of RegIIIbeta/gamma and interferon gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut. Gut 54 (2005) 623-629
8. Hooper L.V., et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4 (2003) 269-273
9. Cash H.L., et al. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313 (2006) 1126-1130
10. Stecher B., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 5 (2007) 2177-2189
11. Lupp C., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of enterobacteriaceae. Cell Host Microbe 2 (2007) 119-129
12. Heimesaat M.M., et al. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS ONE 2 (2007) e662
13. Frank D.N., et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13780-13785
14. Mai V., et al. Monitoring of stool microbiota in subjects with diarrhea indicates distortions in composition. J. Clin. Microbiol. 44 (2006) 4550-4552
15. Voth D.E., and Ballard J.D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18 (2005) 247-263
16. van der Waaij D., et al. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J. Hyg. (Lond.) 69 (1971) 405-411
17. Hapfelmeier S., and Hardt W.D. A mouse model for S. typhimurium-induced enterocolitis. Trends Microbiol. 13 (2005) 497-503
18. McCormick B.A., et al. Roles of motility, chemotaxis, and penetration through and growth in intestinal mucus in the ability of an avirulent strain of Salmonella typhimurium to colonize the large intestine of streptomycin-treated mice. Infect. Immun. 56 (1988) 2209-2217
19. Chang D.E., et al. Carbon nutrition of Escherichia coli in the mouse intestine. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7427-7432
20. Luperchio S.A., and Schauer D.B. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 3 (2001) 333-340
21. Cummings, J.H. (1997) The large intestine in nutrition and disease. Danone Chair Monograph. 103-110, Institute Danone, Bruxelles
22. Iimura M., et al. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol. 174 (2005) 4901-4907
23. Rosenberger C.M., et al. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2422-2427
24. Dann S.M., and Eckmann L. Innate immune defenses in the intestinal tract. Curr. Opin. Gastroenterol. 23 (2007) 115-120
25. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
26. Froy O. Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways. Cell. Microbiol. 7 (2005) 1387-1397
27. Peschel A., and Sahl H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4 (2006) 529-536
28. Bader M.W., et al. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122 (2005) 461-472
29. Navarre W.W., et al. Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. Mol. Microbiol. 56 (2005) 492-508
30. Uzzau S., et al. Differential accumulation of Salmonella[Cu, Zn] superoxide dismutases SodCI and SodCII in intracellular bacteria: correlation with their relative contribution to pathogenicity. Mol. Microbiol. 46 (2002) 147-156
31. Bispham J., et al. Salmonella pathogenicity island 2 influences both systemic salmonellosis and Salmonella-induced enteritis in calves. Infect. Immun. 69 (2001) 367-377
32. Coombes B.K., et al. Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect. Immun. 73 (2005) 7161-7169
33. Rabbani G.H., et al. Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a. Infect. Immun. 63 (1995) 4350-4357
34. Sigel S.P., et al. Ability of an avirulent mutant of Vibrio cholerae to colonize in the infant mouse upper bowel. Infect. Immun. 32 (1981) 474-479
35. Deng W., et al. Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol. Microbiol. 48 (2003) 95-115
36. Margulies M., et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437 (2005) 376-380
37. Turnbaugh P.J., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006) 1027-1031
38. Ley R.E., et al. Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006) 1022-1023
39. Eckburg P.B., and Relman D.A. The role of microbes in Crohn's disease. Clin. Infect. Dis. 44 (2007) 256-262
40. Sauer U., et al. Genetics. Getting closer to the whole picture. Science 316 (2007) 550-551
41. Sonnenburg J.L., et al. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol. 4 (2006) e413
42. Dumont M.G., and Murrell J.C. Stable isotope probing - linking microbial identity to function. Nat. Rev. Microbiol. 3 (2005) 499-504
43. Becker D., et al. Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature 440 (2006) 303-307
44. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31 (1977) 107-133
45. Tannock G.W. Molecular assessment of intestinal microflora. Am. J. Clin. Nutr. 73 (2001) 410S-414S
46. Palmer C., et al. Rapid quantitative profiling of complex microbial populations. Nucleic Acids Res. 34 (2006) e5
47. McCartney A.L. Application of molecular biological methods for studying probiotics and the gut flora. Br. J. Nutr. 88 Suppl 1 (2002) S29-S37
48. Eckburg P.B., et al. Diversity of the human intestinal microbial flora. Science 308 (2005) 1635-1638
49. Gill S.R., et al. Metagenomic analysis of the human distal gut microbiome. Science 312 (2006) 1355-1359
50. Palmer C., et al. Development of the human infant intestinal microbiota. PLoS Biol. 5 (2007) e177
51. Stark P.L., and Lee A. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J. Med. Microbiol. 15 (1982) 189-203
52. Ley R.E., et al. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11070-11075
53. Rozee K.R., et al. Microbial flora of the mouse ileum mucous layer and epithelial surface. Appl. Environ. Microbiol. 43 (1982) 1451-1463
54. Ley R.E., et al. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006) 837-848
55. Nardi R.M., et al. Intragastric infection of germfree and conventional mice with Salmonella typhimurium. Braz. J. Med. Biol. Res. 22 (1989) 1389-1392
56. Freter R. In vivo and in vitro antagonism of intestinal bacteria against Shigella flexneri. II. The inhibitory mechanism. J. Infect. Dis. 110 (1962) 38-46
57. Bammann L.L., et al. Impaired colonization of gnotobiotic and conventional rats by streptomycin-resistant strains of Streptococcus mutans. Infect. Immun. 22 (1978) 721-726
58. Bohnhoff M., et al. Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc. Soc. Exp. Biol. Med. 86 (1954) 132-137
59. Gill H.S. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract. Res. Clin. Gastroenterol. 17 (2003) 755-773
60. Vollaard E.J., and Clasener H.A. Colonization resistance. Antimicrob. Agents Chemother. 38 (1994) 409-414
61. Raqib R., et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9178-9183
62. Heesemann J., et al. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS 101 (1993) 417-429
63. Thorpe C.M. Shiga toxin-producing Escherichia coli infection. Clin. Infect. Dis. 38 (2004) 1298-1303
64. Chen H.D., and Frankel G. Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol. Rev. 29 (2005) 83-98
65. Fernandez M.I., et al. A newborn mouse model for the study of intestinal pathogenesis of shigellosis. Cell. Microbiol. 5 (2003) 481-491
66. Martino M.C., et al. Mucosal lymphoid infiltrate dominates colonic pathological changes in murine experimental shigellosis. J. Infect. Dis. 192 (2005) 136-148
67. Singer M., and Sansonetti P.J. IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. J. Immunol. 173 (2004) 4197-4206
68. Shim D.H., et al. New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies. J. Immunol. 178 (2007) 2476-2482
69. Finkelstein R.A., et al. Pathogenesis experimental cholera in infant rabbits. I. Observations on the intraintestinal infection and experimental cholera produced with cell-free products. J. Infect. Dis. 114 (1964) 203-216
70. Klose K.E. The suckling mouse model of cholera. Trends Microbiol. 8 (2000) 189-191
71. Tsolis R.M., et al. Of mice, calves, and men. Comparison of the mouse typhoid model with other Salmonella infections. Adv. Exp. Med. Biol. 473 (1999) 261-274
72. Rath T., et al. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?. Inflamm. Bowel Dis. 12 (2006) 1025-1035
73. von Lampe B., et al. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47 (2000) 63-73
74. Lawrance I.C., et al. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum. Mol. Genet. 10 (2001) 445-456
75. Ogawa H., et al. Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000) G492-G499
76. Costello C.M., et al. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med. 2 (2005) e199
77. Renes I.B., et al. Distinct epithelial responses in experimental colitis: implications for ion uptake and mucosal protection. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002) G169-G179
78. Lecuit M., et al. Functional genomic studies of the intestinal response to a foodborne enteropathogen in a humanized gnotobiotic mouse model. J. Biol. Chem. 282 (2007) 15065-15072
79. Zhao J., et al. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Gastroenterology 132 (2007) 1331-1343
80. Mehta A., et al. Role of reactive oxygen species in Salmonella typhimurium-induced enterocyte damage. Scand. J. Gastroenterol. 33 (1998) 406-414
81. Robertson J.M., et al. Lack of flagella disadvantages Salmonella enterica serovar Enteritidis during the early stages of infection in the rat. J. Med. Microbiol. 52 (2003) 91-99
82. Ketyi I. Feeding by mucin and intestinal growth of some enteric bacterial pathogens. Acta Microbiol. Hung. 35 (1988) 389-395
83. Deplancke B., and Gaskins H.R. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am. J. Clin. Nutr. 73 (2001) 1131S-1141S
84. Stecher B., et al. Comparison of Salmonella enterica serovar typhimurium colitis in germfree mice and mice pretreated with streptomycin. Infect. Immun. 73 (2005) 3228-3241